COLA: Oral Challenges to Food

Price: $25 members, $35 non-members
Session recorded on August 17, 2018
Speaker: Justin Greiwe, MD
Viewers can earn credit by completing the posttest questions.

Physicians will acquire a better understanding of the strengths and weaknesses of current food allergy diagnostic modalities as well as novel diagnostic methods currently under active study. They will respect the different types of food immunotherapy currently under investigation, with a focus on OIT. There will be a review of the history of OIT and examine the current evidence supporting OITs use. In doing so participants will be able to recognize the risks and limitations associated with OIT, identify which patients might benefit from this therapy, and have a clearer understanding of how OIT fits in a busy clinical practice

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support

There is no commercial support for this activity.

Target Audience

Practicing allergists/immunologists

Fellows-in-Training

Learning Objectives

- Acquire a better understanding of the strengths and weaknesses of current food allergy diagnostic modalities as well as novel diagnostic methods currently under active study

- Recognize different types of immunotherapy approaches to treat food allergy and identify which patients can benefit

- Assess the risks and limitations associated with OIT

- Consider the future of food immunotherapy in clinical practice

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  The ACCME defines a “commercial interest” as any entity producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients.  The ACCME does not consider providers of clinical service directly to patients to be commercial interests.  For more information, visit www.accme.org.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Jay Portnoy, MD (Planner)

Speaker, honorarium: Thermofisher, Boehringer Ingelheim

The following have no financial relationships to disclose:

Paul Dowling MD (Planner)

Justin Greiwe, MD (Speaker)


 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
08/17/2018
Course expires: 
12/31/2018
Cost:
$35.00
Rating: 
0

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
08/17/2018
Course expires: 
12/31/2018

Price

Cost:
$35.00
Please login or create an account to take this course.